The global digital pathology market revenue was around US$ 878.9 million in 2022 and is estimated to reach US$ 1956.6 million by 2031, growing at a compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031.
Digital pathology is an image-based information and computer-enabled platform that assists in the management of information generated from digital slides. Digital pathology technology can help a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange tissue microarrays, macroscopic images, and entire slide images.
Market Driving Factors
Rapid digitization in pathology to boost market growth. The surging demand for digitization in pathology has given rise to competition among market players in the digital pathology market. In addition, rising competition connected with the surging need for drug discovery through applications of high throughput algorithms in the market has encouraged main players to finance in developing novel tools to facilitate workload and customization.
For instance, in March 2022, Nucleai declared that it raised a Series B funding of US$ 33 million. The company is a developer of an AI-powered pathology platform seeking to indicate a patient's response to treatment. The investment will help the company's continued development of its platform and grow its existence among contract research organizations and biopharma companies.
Increasing use of AI (Artificial Intelligence) in healthcare drives market growth. The usage of AI in healthcare is growing, with an increasing focus on enhancing patient care quality by incorporating AI into different aspects of healthcare services, such as pathological diagnosis. As a result, artificial intelligence offers smooth primary care flow and automation, allowing doctors to concentrate on more important and terrible patients. Furthermore, AI solutions in the healthcare industry are becoming more humanized.
The high price of digital pathology and the lower adoption rate in underdeveloped and emerging countries will restrain market growth.
Regional Analysis
North America dominated the market. This can be attributed to the surge in government initiatives leading to the development of technologically cutting-edge pathologies, increasing adoption of digital imaging, continual deployment of R&D investments, and presence of key players in the region concentrating on offering better solutions to the population.
Asia Pacific is expected to dominate the market. This is due to rapid digitalization, an increasing emphasis on investments in the medical field, and a surge in digital imaging penetration in developing economies. Furthermore, this region shows a rising prevalence of cancer which drives the need for novel treatment options and boosts market expansion. For instance, in March 2023, Qritive entered into collaboration with Corista for the integration of AI (Artificial Intelligence) using the company’s DP3, a DICOM-compliant pathology software in digital pathology. Such initiatives assist in providing better patient care, with novel treatment options, and subsequently reducing laboratory cost expenses.
Segmentation Insights
Product Insight
The software segment is expected to register the fastest growth rate over the forecast period. This growth is attributed to the increasing number of cancer cases with key players concentrating on the development of novel digital pathology systems in the industry.
Application Insight
The disease diagnosis segment is predicted to dominate the market This is due to the surge in prevalence of chronic diseases, and the rising focus of manufacturers for the development of rapid and novel diagnostics procedures for ease in the circulation of inter and intra-departmental information. In addition, the digital adoption of technologies aids in enhancing and improving the efficiency of disease diagnosis and therapeutics.
End User Insight
The pharma & biotech companies segment dominated the market. This can be attributed to the large number of key players providing digital pathology systems, the increase in demand for educational practices, advancement in R&D activities, and the development of novel & innovative pathology systems.
Prominent Companies
Segmentation Outline
The global digital pathology market segmentation focuses on Product, Application, End User, and Region.
By Product
By Application
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL DIGITAL PATHOLOGY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: DIGITAL PATHOLOGY MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL DIGITAL PATHOLOGY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 SCANNERS
5.3 SOFTWARE
5.4 STORAGE AND COMMUNICATION SYSTEMS
6 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 TELECONSULTATION
6.3 DISEASE DIAGNOSIS
6.4 DRUG DISCOVERY
6.5 TRAINING & EDUCATION
7 GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER
7.1 OVERVIEW
7.2 EDUCATIONAL
7.3 CLINICAL
7.4 PHARMA & BIOTECH COMPANIES
8 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL DIGITAL PATHOLOGY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 PERKINELMER INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 F- HOFFMANN LA-ROCHE AG
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 INDICA LABS INC
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 VISIOPHARM A/S
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 KONINKLIJKE PHILIPS N.V.
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 GLENCOE SOFTWARE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 HAMAMATSU PHOTONICS K.K.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 DANAHER CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 NIKON CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 3DHISTECH LTD
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved